Search Results

Baricitinib (LY3009104, INCB028050) 10mM (in 1mL DMSO)  | 98.06%

APEXBIO TECHNOLOGY LLC

JAK1/JAK2 inhibitor,selective orally bioavailable Chromatin/Epigenetics|JAK

More Information Supplier Page

×

Baricitinib (LY3009104, INCB028050)

Baricitinib (LY3009104, INCB028050) 5mg  | 98.06%

APEXBIO TECHNOLOGY LLC

JAK1/JAK2 inhibitor,selective orally bioavailable Chromatin/Epigenetics|JAK

More Information Supplier Page

×

Baricitinib (LY3009104, INCB028050)

Baricitinib (LY3009104, INCB028050) 10mg  | 98.06%

APEXBIO TECHNOLOGY LLC

JAK1/JAK2 inhibitor,selective orally bioavailable Chromatin/Epigenetics|JAK

More Information Supplier Page

×

Baricitinib (LY3009104, INCB028050)

WP1066 Evaluation Sample  | 99.84%

APEXBIO TECHNOLOGY LLC

JAK2/STAT3 inhibitor,cell-permeable Chromatin/Epigenetics|JAK

More Information Supplier Page

×

WP1066

WP1066 10mM (in 1mL DMSO)  | 99.84%

APEXBIO TECHNOLOGY LLC

JAK2/STAT3 inhibitor,cell-permeable Chromatin/Epigenetics|JAK

More Information Supplier Page

×

WP1066

AG-490 25mg  | 99.8%

APEXBIO TECHNOLOGY LLC

JAK2/EGFR inhibitor JAK/STAT Signaling|EGFR

More Information Supplier Page

×

AG-490

AG-490 10mg  | 99.8%

APEXBIO TECHNOLOGY LLC

JAK2/EGFR inhibitor JAK/STAT Signaling|EGFR

More Information Supplier Page

×

AG-490

AG-490 10mM (in 1mL DMSO)  | 99.8%

APEXBIO TECHNOLOGY LLC

JAK2/EGFR inhibitor JAK/STAT Signaling|EGFR

More Information Supplier Page

×

AG-490

AZD1480 50mg  | 98.01%

APEXBIO TECHNOLOGY LLC

JAK2 inhibitor,ATP-competitive and novel Chromatin/Epigenetics|JAK

More Information Supplier Page

×

AZD1480

AZD1480 200mg  | 98.01%

APEXBIO TECHNOLOGY LLC

JAK2 inhibitor,ATP-competitive and novel Chromatin/Epigenetics|JAK

More Information Supplier Page

×

AZD1480